Category: Fellows Posters
Purpose: The opioid crisis is one of the most pressing issues affecting healthcare today. Consequently, decreasing opioid usage has been at the forefront of public health initiatives. One such initiative is the use of multimodal medication admixtures for surgical pain management. These “cocktails” comprise of various combinations of non-steroidal anti-inflammatory drugs, sodium-channel blockers, and N-Methyl-D-aspartate receptor antagonists as opioid alternatives. One admixture, BKK, uses the combination of bupivacaine, ketorolac, and ketamine. The aim of this study is to evaluate the use of BKK within surgical procedures compared to alternative pain management modalities, and ultimately determine any potential clinical or financial implications.
Methods: This study is a retrospective cohort analysis conducted at multiple hospitals within a large health system. Patients included in this study underwent surgical procedures at hospitals utilizing BKK between May 1, 2019 and October 1, 2019. Patients who received BKK will be compared against patients who underwent similar surgical procedures, but received alternative non-opioid analgesics such as Exparel® (bupivacaine) and ropivacaine. Data collected include type of surgical analgesic used, type of surgery, pain scores, post-operative pain treatment modalities, and length of stay. Patient demographics including age, gender, weight, BMI, and comorbidities will also be collected. The primary endpoint compared in this study will be the average pain scores post-surgery. Secondary endpoints that will be measured are peak pain scores, total consumption of opioids and non-opioids for pain management, and total length of stay.